{"nctId":"NCT00396565","briefTitle":"A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia","startDateStruct":{"date":"2006-07"},"conditions":["Schizophrenia"],"count":394,"armGroups":[{"label":"ER OROS paliperidone","type":"EXPERIMENTAL","interventionNames":["Drug: ER OROS paliperidone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Olanzapine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Olanzapine"]}],"interventions":[{"name":"ER OROS paliperidone","otherNames":[]},{"name":"Placebo","otherNames":[]},{"name":"Olanzapine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who have given their own consent in writing to participate in the study\n* Patients diagnosed with schizophrenia according to the diagnostic criteria of DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 295.30, 295.10, 295.20, 295.90, 295.60)\n* Patients who have acute symptoms of schizophrenia\n* Both inpatients and outpatients are acceptable\n\nExclusion Criteria:\n\n* A DSM-IV (Diagnostic and Statistical Manual of Mental Disorders) of a mental disease diagnosis other than schizophrenia\n* A DSM-IV diagnosis of substance-related disorder (except nicotine dependence and caffeine dependence) within 180 days before the screening test\n* Total PANSS (Positive and Negative Syndrome System) score at the screening test \\<70 or \\>120\n* Patients treated with three or more types of antipsychotic within 28 days before the screening test\n* Parkinson's disease (except for those with drug-induced extra pyramidal symptoms)\n* Patients with a complication of or a past history of cerebrovascular accident\n* Patients with a complication of or a past history of diabetes mellitus","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in the Total Positive and Negative Syndrome Scale (PANSS).","description":"PANSS is a medical scale that assesses various symptoms of schizophrenia. The symptoms are rated on a 7-point scale from 1 (absent) to 7 (extreme psychopathology). The total score is the sum of all 30 PANSS items, with a range of 30 (absent) to 210 (extreme ill).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.1","spread":"18.39"},{"groupId":"OG001","value":"3.8","spread":"18.88"},{"groupId":"OG002","value":"-9.9","spread":"16.83"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Positive and Negative Syndrome Scale (PANSS) - Positive Subscale Score","description":"The PANSS Positive Subscale assesses seven positive-symptoms of schizophrenia. Positive symptoms refer to an excess or distortion of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.6","spread":"5.69"},{"groupId":"OG001","value":"1.6","spread":"5.53"},{"groupId":"OG002","value":"-2.4","spread":"5.34"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Positive and Negative Syndrome Scale (PANSS) - Negative Subscale Score","description":"The PANSS Negative Subscale assesses seven negative-symptoms of schizophrenia. Negative symptoms represent a diminution or loss of normal functions. The symptoms are rated on a 7-point scale, with a range of 7 (absent) to 49 (extreme psychopathology).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.4","spread":"5.05"},{"groupId":"OG001","value":"0.0","spread":"5.02"},{"groupId":"OG002","value":"-2.8","spread":"4.27"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Positive and Negative Syndrome Scale (PANSS) - General Psychopathology Subscale Score","description":"The PANSS General Psychopathology Subscale Score assesses 16 general psychopathology symptoms. The symptoms are rated on a 7-point scale, with a range of 16 (absent) to 112 (extreme psychopathology).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.1","spread":"9.52"},{"groupId":"OG001","value":"2.2","spread":"10.71"},{"groupId":"OG002","value":"-4.7","spread":"9.00"}]}]}]},{"type":"SECONDARY","title":"Proportion of Responders (â‰¥30% Decrease in Total Positive and Negative Syndrome Scale [PANSS])","description":"Responders are subjects with 30% or more reduction from baseline in total PANSS score. PANSS is a medical scale that assesses various symptoms of schizophrenia. The symptoms are rated on a 7-point scale from 1 (absent) to 7 (extreme psychopathology). The total score is the sum of all 30 PANSS items, with a range of 30 (absent) to 210 (extreme ill).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25.4","spread":null},{"groupId":"OG001","value":"9.4","spread":null},{"groupId":"OG002","value":"26.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Clinical Global Impression Scale (CGI-S)","description":"The CGI-S rating scale is a 7-point global assessment with scores as follows: 1 - Not ill, 2 - Very Mild, 3 - Mild, 4 - Moderate, 5 - Marked, 6 - Severe, and 7 - Extremely Severe.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.4","spread":"0.09"},{"groupId":"OG001","value":"0.2","spread":"0.09"},{"groupId":"OG002","value":"-0.3","spread":"0.14"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":134},"commonTop":["schizophrenia","Insomnia","Nasopharyngitis","Blood creatine phosphokinase increased","Constipation"]}}}